{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:11:52Z","timestamp":1789809112712,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00592-016-0882-9","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T05:51:46Z","timestamp":1467697906000},"page":"839-844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Dipeptidyl peptidase-4 inhibitors and bone metabolism: is vitamin D the link?"],"prefix":"10.1007","volume":"53","author":[{"given":"I.","family":"Barchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bloise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"key":"882_CR1","first-page":"223","volume":"27","author":"WD Leslie","year":"2007","unstructured":"Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2007) Type 2 diabetes and bone. J Bone Miner Res 27:223\u20132237","journal-title":"J Bone Miner Res"},{"issue":"1","key":"882_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00592-011-0347-0","volume":"50","author":"R Reyes-Garc\u00eda","year":"2013","unstructured":"Reyes-Garc\u00eda R, Rozas-Moreno P, L\u00f3pez-Gallardo G, Garc\u00eda-Mart\u00edn A, Varsavsky M, Avil\u00e9s-Perez MD et al (2013) Serum levels of bone resorption markers are decreased in patients with type 2 diabetes. Acta Diabetol 50(1):47\u201352","journal-title":"Acta Diabetol"},{"key":"882_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00592-011-0324-7","volume":"49","author":"EJ Hamilton","year":"2012","unstructured":"Hamilton EJ, Rakic V, Davis WA, Paul Chubb SA, Kamber N, Prince RL (2012) A five-year prospective study of bone mineral density in men and women with diabetes: the fremantle diabetes study. Acta Diabetol 49:153\u2013158","journal-title":"Acta Diabetol"},{"key":"882_CR4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.phrs.2015.08.023","volume":"100","author":"L Baerts","year":"2015","unstructured":"Baerts L, Glorie L, Maho W, Eelen A, Verhulst A, D\u2019Haese P et al (2015) Potential impact of sitagliptin on collagen-derived dipeptides in diabetic osteoporosis. Pharmacol Res 100:336\u2013340","journal-title":"Pharmacol Res"},{"key":"882_CR5","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1152\/ajpendo.00217.2014","volume":"307","author":"L Glorie","year":"2014","unstructured":"Glorie L, Behets GJ, Baerts L, De Meester I, D\u2019Haese PC, Verhulst A (2014) DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats. Am J Physiol Endocrinol Metab 307:E447\u2013E455","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"882_CR6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","volume":"149","author":"C Yamada","year":"2008","unstructured":"Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N et al (2008) The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology 149:574\u2013579","journal-title":"Endocrinology"},{"key":"882_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00774-014-0581-y","volume":"33","author":"SK Hegazy","year":"2015","unstructured":"Hegazy SK (2015) Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women. J Bone Miner Metab 33:207\u2013212","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"882_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbrc.2013.03.010","volume":"434","author":"M Nabeno","year":"2013","unstructured":"Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S et al (2013) A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site. Biochem Biophys Res Commun 434(2):191\u2013196","journal-title":"Biochem Biophys Res Commun"},{"key":"882_CR9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dmrr.2502","volume":"30","author":"B Hirshberg","year":"2014","unstructured":"Hirshberg B, Parker A, Edelberg H, Donovan M, Iqbal N (2014) Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 30:556\u2013569","journal-title":"Diabetes Metab Res Rev"},{"key":"882_CR10","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/dc15-1068","volume":"38","author":"O Mosenzon","year":"2015","unstructured":"Mosenzon O, Wei C, Davidson J, Scirica BM, Yanuv I, Rozenberg A et al (2015) Incidence of fractures in patients with type 2 diabetes in the SAVOR-TIMI 53 trial. Diabetes Care 38:2142\u20132150","journal-title":"Diabetes Care"},{"key":"882_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1753-0407.2011.00168.x","volume":"4","author":"MC Bunck","year":"2012","unstructured":"Bunck MC, Poelma M, Eekhoff EM, Schweizer A, Heine RJ, Nijpels G et al (2012) Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients. J Diabetes 4:181\u2013185","journal-title":"J Diabetes"},{"key":"882_CR12","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1210\/jc.2015-2233","volume":"100","author":"T Zheng","year":"2015","unstructured":"Zheng T, Yang L, Liu Y, Liu H, Yu J, Zhang X et al (2015) Plasma DPP4 activities are associated with osteoporosis in postmenopausal women with normal glucose tolerance. J Clin Endocrinol Metab 100:3862\u20133870","journal-title":"J Clin Endocrinol Metab"},{"key":"882_CR13","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.2337\/dc11-1099","volume":"34","author":"M Monami","year":"2011","unstructured":"Monami M, Dicembrini I, Antenore A, Mannucci E (2011) Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials. Diabetes Care 34:2474\u20132476","journal-title":"Diabetes Care"},{"key":"882_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/dmrr.2466","volume":"30","author":"EJ Gallagher","year":"2014","unstructured":"Gallagher EJ, Sun H, Kornhauser C et al (2014) The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes. Diabetes Metab Res Rev 30:191\u2013200","journal-title":"Diabetes Metab Res Rev"},{"key":"882_CR15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12102","volume":"6","author":"G Mabilleau","year":"2014","unstructured":"Mabilleau G, Mieczkowska A, Chappard D (2014) Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials. J Diabetes 6:260\u2013266","journal-title":"J Diabetes"},{"issue":"1","key":"882_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","volume":"48","author":"B Su","year":"2015","unstructured":"Su B, Sheng H, Zhang M, Bu L, Yang P, Li L et al (2015) Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists\u2019 treatment: a meta-analysis of randomized controlled trials. Endocrine 48(1):107\u2013115","journal-title":"Endocrine"},{"issue":"2","key":"882_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-015-9993-5","volume":"97","author":"JH Driessen","year":"2015","unstructured":"Driessen JH, Henry RM, van Onzenoort HA, Lalmohamed A, Burden AM, Prieto-Alhambra D et al (2015) Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int 97(2):104\u2013112","journal-title":"Calcif Tissue Int"},{"key":"882_CR18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00592-015-0792-2","volume":"52","author":"R Li","year":"2015","unstructured":"Li R, Xu W, Luo S, Xu H, Tong G, Zeng L et al (2015) Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. Acta Diabetol 52:1083\u20131091","journal-title":"Acta Diabetol"},{"issue":"6","key":"882_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/nu8060319","volume":"8","author":"E Wintermeyer","year":"2016","unstructured":"Wintermeyer E, Ihle C, Ehnert S et al (2016) Crucial role of vitamin D in the musculoskeletal system. Nutrients 8(6). doi: 10.3390\/nu8060319","journal-title":"Nutrients"},{"key":"882_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00592-013-0540-4","volume":"51","author":"S Maggi","year":"2014","unstructured":"Maggi S, Siviero P, Brocco E, Albertin M, Romanato G, Crepaldi G (2014) Vitamin D deficiency, serum leptin and osteoprotegerin levels in older diabetic patients: an input to new research avenues. Acta Diabetol 51:461\u2013469","journal-title":"Acta Diabetol"},{"issue":"2","key":"882_CR21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2013.11.011","volume":"150","author":"M Tejera-Alhambra","year":"2014","unstructured":"Tejera-Alhambra M, Casrouge A, de Andr\u00e9s C, Ramos-Medina R, Alonso B, Vega J et al (2014) Low DPP4 expression and activity in multiple sclerosis. Clin Immunol 150(2):170\u2013183","journal-title":"Clin Immunol"},{"key":"882_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"882_CR23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00198-010-1285-3","volume":"21","author":"B Dawson-Hughes","year":"2010","unstructured":"Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21:1151\u20131154","journal-title":"Osteoporos Int"},{"key":"882_CR24","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","volume":"6","author":"D R\u00f6hrborn","year":"2015","unstructured":"R\u00f6hrborn D, Wronkowitz N, Eckel J (2015) DPP4 in diabetes. Front Immunol 6:386","journal-title":"Front Immunol"},{"issue":"11","key":"882_CR25","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/en.2013-1969","volume":"155","author":"E Zoico","year":"2014","unstructured":"Zoico E, Franceschetti G, Chirumbolo S, Rossi AP, Mazzali G, Rizzatti V et al (2014) Phenotypic shift of adipocytes by cholecalciferol and 1\u03b1, 25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. Endocrinology 155(11):4178\u20134188","journal-title":"Endocrinology"},{"issue":"12","key":"882_CR26","doi-asserted-by":"crossref","first-page":"e52171","DOI":"10.1371\/journal.pone.0052171","volume":"7","author":"H Nimitphong","year":"2012","unstructured":"Nimitphong H, Holick MF, Fried SK, Lee MJ (2012) 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D promote the differentiation of human subcutaneous preadipocytes. PLoS One 7(12):e52171","journal-title":"PLoS One"},{"issue":"1","key":"882_CR27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0029665115004164","volume":"75","author":"JF Landrier","year":"2016","unstructured":"Landrier JF, Karkeni E, Marcotorchino J, Bonnet L, Tourniaire F (2016) Vitamin D modulates adipose tissue biology: possible consequences for obesity? Proc Nutr Soc 75(1):38\u201346 (Epub 2015 Nov 13)","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"882_CR28","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1210\/en.2014-1647","volume":"156","author":"E Karkeni","year":"2015","unstructured":"Karkeni E, Marcotorchino J, Tourniaire F, Astier J, Peiretti F, Darmon P et al (2015) Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology 156(5):1782\u20131793","journal-title":"Endocrinology"},{"key":"882_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12933-015-0250-z","volume":"14","author":"YH Krul-Poel","year":"2015","unstructured":"Krul-Poel YH, Agca R, Lips P, van Wijland H, Stam F, Simsek S (2015) Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report. Cardiovasc Diabetol 14:89","journal-title":"Cardiovasc Diabetol"},{"key":"882_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12933-015-0176-5","volume":"14","author":"S Yamagishi","year":"2015","unstructured":"Yamagishi S, Fukami K, Matsui T (2015) Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol 14:2","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"882_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.111.191098","volume":"342","author":"C Sch\u00fcrmann","year":"2012","unstructured":"Sch\u00fcrmann C, Linke A, Engelmann-Pilger K, Steinmetz C, Mark M, Pfeilschifter J et al (2012) The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob\/ob mice. J Pharmacol Exp Ther 342(1):71\u201380","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0882-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-016-0882-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-016-0882-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:49:22Z","timestamp":1498326562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-016-0882-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1007\/s00592-016-0882-9","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,5]]}}}